# Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria

PMC · DOI: 10.1371/journal.pone.0321797 · PLOS One · 2025-04-04

## Full-text entities

- **Diseases:** multi-drug resistant tuberculosis (MESH:D018088)
- **Chemicals:** rifampicin (MESH:D012293)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11970690/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11970690/full.md

---
Source: https://tomesphere.com/paper/PMC11970690